April 8 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA PRESENTS DATA DEMONSTRATING LUPKYNIS™ (VOCLOSPORIN) EFFICACY ACROSS LUPUS NEPHRITIS BIOPSY CLASSES AT NATIONAL KIDNEY FOUNDATION 2021 SPRING CLINICAL MEETINGS
April 8 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA PRESENTS DATA DEMONSTRATING LUPKYNIS™ (VOCLOSPORIN) EFFICACY ACROSS LUPUS NEPHRITIS BIOPSY CLASSES AT NATIONAL KIDNEY FOUNDATION 2021 SPRING CLINICAL MEETINGS